CDMO News

Grifols Partnership: Specialists in added-value injectable products

Grifols

Grifols Partnership, is a contract development and manufacturer (CDMO) focused on added-value injectable products for small molecules, headquartered in Barcelona, Spain.

In this episode of the PharmaSource podcast, Marga ViƱes Senior Business Development Manager for Grifols contract manufacturing, explains the drug development and manufacturing services that they offer to customers.

ā€œGrifols is mainly known in the blood-derivatives field.ā€ says Marga.  Additionally the companyā€™s ā€œcontract manufacturing experience in injectable drugs led to us offering CDMO services focusing on Orphan drugs. We are very specialised in small-volume parenteral manufacturing.ā€

The trend from Blockbuster to Nichebuster

Grifols Partnership typically focus their contract manufacturing expertise on developing smaller-scale programmes targeting rare diseases in the United States and Europe.

ā€œThe industry is becoming more focused on orphan drugs rather than the development of blockbuster drugs with large populationsā€ says Marga. 

ā€œThe shift is being driven in part by new legislation. This paradigm creates opportunities for smaller pharma and biotech to bring new medicines to the market.ā€


Quality by Design

A differentiator for Grifols is their ā€œQuality by designā€ philosophy, which goes beyond operating FDA, EMA and GMP-approved facilities. 

ā€œWe have implemented a qualityā€byā€design approach to process development and enhanced our process control capabilities. We also have an established change management control system and have introduced automation technologies to further minimise the potential for error and contamination in our parenteral products.ā€ says Marga,

ā€œAt Grifols, safety is more than just a regulatory requirement.  It is methodology that steers all operational decisions as we all strive to improve the wellbeing of patients and their quality of life.ā€

An example of this is how Grifols manufactures their own flexible bags on-site to obtain a perfect match between the drug and its container. This vertical integration model enables the CDMO to control the entire process and ensure the highest standards of quality at all stages of manufacturing.

Meet the Grifols Partnership team at CDMO Live 2024. Find out more here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam forĀ an exclusive live event dedicated to contract manufacturing partnerships.Ā Apply for your ticket.

Sign up to our free weekly newsletter for all the latest contract manufacturing news.  Register here

ELEARNING

Learn the essentials of successful biopharma outsourcing

New eLearning course distilsĀ 100+Ā expert interviews intoĀ 10Ā engaging modules.

tickĀ Overview of outsourcing trendsĀ 
tickĀ Expert insights and case studiesĀ 
tickĀ Helpful resources and quizzes

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.